Company intelligence / Profile preview

Bluecrux

Aalst, Belgium

Ownership: Private
Employees: ~300
Development stage: Other

Overview

Bluecrux has demonstrated success in global supply chain transformation, consults for leading biopharma firms, and its Binocs platform is widely used for real-time CGT/patient journey scheduling and resource orchestration.

Modalities: Cell therapyGene therapyBiologicAdvanced therapiesPatient-specific products
Industry: Consulting

Partnerships

Johnson & JohnsonGSKRocheAkzoNobelBridgestoneBeiersdorfOatlyEtexKenvue

Beyond the preview

Go deeper on Bluecrux.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bluecrux.

Explore the full profile